CIBC World Market’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11
Closed -$2K 1330
2022
Q4
$2K Sell
11
-55
-83% -$23.8K ﹤0.01% 1238
2022
Q3
$33K Hold
66
﹤0.01% 1205
2022
Q2
$57K Hold
66
﹤0.01% 1222
2022
Q1
$165K Hold
66
﹤0.01% 1225
2021
Q4
$169K Buy
66
+55
+500% +$220K ﹤0.01% 1269
2021
Q3
$51K Hold
11
﹤0.01% 1310
2021
Q2
$76K Buy
+11
New +$75.9K ﹤0.01% 1308

Other funds holding RDHL

CIBC World Market's RDHL Position: Q1 2023 in Review

CIBC World Market sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 11 shares — an estimated $2K sold.

CIBC World Market first reported a position in RDHL in Q2 2021 and held it in 7 quarters. The position peaked at $169K in Q4 2021. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • CIBC World Market reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • CIBC World Market sold 11 Redhill Biopharma shares in Q1 2023, an estimated $2K.
  • CIBC World Market first reported a position in Redhill Biopharma in Q2 2021 and held it in 7 quarters.
  • CIBC World Market's Redhill Biopharma position peaked at $169K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on CIBC World Market's 13F filing for Q1 2023, filed 12 May 2023.